By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


PharmAthene, Inc. 

One Park Place
Suite 450
Annapolis  Maryland  21401  U.S.A.
Phone: 410-269-2600 Fax: 410-269-2601



Start Up

Company News
PharmAthene, Inc. (PIP) Reports Year-End 2014 Financial And Operational Results; Announces Plan To Realign Operational Resources 3/10/2015 7:48:31 AM
PharmAthene, Inc. (PIP) rPA Antigen Formulated With DepoVax™ Demonstrates Promise As Single Unit Dose Anthrax Vaccine 2/2/2015 10:28:06 AM
PharmAthene, Inc. (PIP) Awarded $195 Million Plus Post-Judgment Interest By Delaware Court Of Chancery 1/16/2015 9:54:46 AM
Court Orders SIGA Technologies, Inc. (SIGA) to Pay PharmAthene, Inc. (PIP) $113 Million 1/8/2015 6:03:46 AM
PharmAthene, Inc. (PIP) Fulfills Valortim IDIQ Contract 11/20/2014 12:39:53 PM
PharmAthene, Inc. (PIP) Provides Third Quarter 2014 Operational And Financial Update 11/7/2014 7:53:29 AM
PharmAthene, Inc. (PIP) Announces U.S. Bankruptcy Court Partially Lifts Litigation Stay To Permit Delaware Court To Proceed Towards Final Judgment 10/8/2014 10:47:19 AM
PharmAthene, Inc. (PIP) Awarded Contract Of Up To $28.1 Million To Develop Next Generation Thermostable Anthrax Vaccine 9/10/2014 9:17:17 AM
PharmAthene, Inc. (PIP) Release: New Non-Clinical Data Demonstrate SparVax┬« Provides Equivalent Protection In Head-To-Head Comparison With BioThrax┬« 9/9/2014 8:17:26 AM
PharmAthene, Inc. (PIP) And Nanotherapeutics Form Strategic Alliance To Advance Biodefense Programs 9/8/2014 10:52:30 AM